Zobrazeno 1 - 10
of 241
pro vyhledávání: '"35"'
Publikováno v:
Gynecologic oncology. 117(1)
Objective The aim of this study was to evaluate clinicopathologic characteristics, long-term outcome and reproductive function in women diagnosed with pure dysgerminoma of the ovary. Methods Sixty-five women with stage IA to IIIC pure ovarian dysgerm
Publikováno v:
Gynecologic oncology. 95(2)
Objectives. The incidence of hypersensitivity reactions (HR) is increased in patients treated with multiple courses of carboplatin. The purposes of this investigation were to evaluate the effectiveness of a 12-step desensitization protocol and to cha
Autor:
Shephali Mathure, Linda F. Carson, Karuna P. Murray, Anil Kaul, Shah Khan, Rashmi Kaul, Leo B. Twiggs, Mark G. Martens
Publikováno v:
Gynecologic oncology. 76(2)
Objective. Complement system plays an important role in host defense mechanisms against microorganisms and tumor cells. To protect themselves from autologous complement-mediated damage, normal host tissues express cell membrane-associated complement
Publikováno v:
Gynecologic oncology. 31(3)
This retrospective study involved 55 patients, 35 years old or less with invasive carcinoma of the cervix. There were 49 squamous carcinomas, 3 adenocarcinomas, and 3 unusual varieties. Thirty-five patients had stage IB disease; 4 had stage IIA disea
Publikováno v:
Gynecologic oncology. 30(2)
Forty-five patients with invasive cervical squamous cell carcinoma were registered in the Tom Baker Cancer Centre from 1980 to 1985. The natural history of 22 patients (48.9%) who developed persistent or recurrent disease including 11 Stage IB, 8 Sta
Autor:
Seamus McDonald, Yanmei Huang, Feras Abu Saadeh, Waseem Kamran, N. Ibrahim, Elizabeth A. Heron, Lucy A. Norris, Cliona Murphy, Nadine Farah, Rizmee Shireen, Noreen Gleeson, Tom D'Arcy, Megan Power Foley, Sharon O'Toole, C. Thompson, Mark Ward, John J. O'Leary
Publikováno v:
Gynecologic Oncology. 160:514-519
To investigate whether HE4 and CA125 could identify endometrioid adenocarcinoma patients who might most benefit from full staging surgery with lymphadenectomy.Sequential patients with a preoperative banked serum and histology of endometrioid adenocar
Publikováno v:
Gynecologic Oncology. 158:231-235
To evaluate the feasibility of cervical conization and laparoscopic pelvic lymphadenectomy as a fertility-sparing surgery to treat early-stage cervical cancer.We conducted a retrospective analysis from a prospectively maintained database of patients
Autor:
Ameli Tropé, Gry Baadstrand Skare, Agnes Kathrine Lie, Stefan Lönnberg, K. Brusegard, Christine M. Jonassen, Tone Bjørge
Publikováno v:
Gynecologic Oncology. 148:111-117
To explore the HPVgenotype profile in Norwegian women with ASC-US/LSIL cytology and the subsequent risk of high-grade cervical neoplasia (CIN 3+).In this observational study delayed triage of ASC-US/LSIL of 6058 women were included from 2005 to 2010.
Autor:
Leigha Senter, Beth Y. Karlan, Henry T. Lynch, Christian F. Singer, Jacek Gronwald, Susan L. Neuhausen, Andrea Eisen, Barry P. Rosen, Joanne Kotsopoulos, Steven A. Narod, Jan Lubinski, Ping Sun, Pål Møller, William D. Foulkes, Peter Ainsworth, Nadine Tung, Tomasz Huzarski
Publikováno v:
Gynecologic oncology. 150(1)
Objectives For women at high risk of developing ovarian cancer, it is important to provide an accurate recommendation for the optimal age for preventive surgery in order to maximize the preventative effect while delaying symptoms associated with earl
Autor:
Lainie P. Martin, Albert J. Bonebrake, Lisa M. Landrum, David S. Alberts, John A. Blessing, Stephen L. Rose, David P. Warshal, Lois M. Ramondetta
Publikováno v:
Gynecologic Oncology. 127:451-455
Background Metastatic and recurrent, platinum resistant cervix cancer has an extremely poor prognosis. The Gynecologic Oncology Group has studied > 20 cytotoxic drugs or drug combinations in the second-line, phase II setting of advanced, drug resista